Salt-Wasting Crisis in a 46,XX Infant With Ambiguous Genitalia
A 3-week-old 46,XX infant presents with vomiting, poor feeding, and dehydration. Weight is 3.2 kg (birth weight 3.6 kg). Serum sodium 128 mmol/L, potassium 6.2 mmol/L, glucose 45 mg/dL, pH 7.25, bicarbonate 14 mmol/L. Blood pressure is borderline low. Examination shows clitoromegaly and fused labioscrotal folds. The parents are consanguineous and ask whether this is a 'girl or boy' and whether the condition is inherited. The infant has not been started on any medication. The emergency department wants to give normal saline and wait for 17-hydroxyprogesterone results.
1. What is your immediate management in the emergency department? What fluids and medications would you give, and what would you avoid?
Read the worked answer
This is a salt-wasting adrenal crisis until proven otherwise, likely congenital adrenal hyperplasia. I would not wait for 17-hydroxyprogesterone before treating. I would obtain glucose, electrolytes, blood gas, cortisol, ACTH, renin, aldosterone, 17-hydroxyprogesterone, and karyotype, but treatment should start immediately. I would give a bolus of 0.9% saline with dextrose for shock or poor perfusion, then maintain fluids with 0.9% saline plus glucose; I would avoid potassium-containing fluids and avoid giving potassium. For hypoglycemia, give dextrose. I would give stress-dose hydrocortisone intravenously (for example 50–100 mg/m2) and arrange repeated dosing every 6 hours until stable. Fludrocortisone is usually added once the infant is stabilized and electrolytes are being corrected. I would monitor sodium, potassium, glucose, and blood pressure closely.
2. How do you confirm the diagnosis, and what are the pitfalls of interpreting 17-hydroxyprogesterone in a sick neonate?
Read the worked answer
The diagnosis is confirmed by a markedly elevated 17-hydroxyprogesterone in the context of virilization in a 46,XX infant, hyponatremia, hyperkalemia, and hypoglycemia. I would also check electrolytes, plasma renin activity, aldosterone, cortisol, ACTH, and karyotype. The pitfall is that 17-hydroxyprogesterone can be falsely elevated in acute stress, prematurity, and illness, so a single borderline value is not diagnostic. A very high value is supportive, but I would repeat after stabilization and consider confirmatory genetic testing of CYP21A2. In a 46,XX infant with ambiguous genitalia, the finding of a uterus on ultrasound also supports CAH rather than a testosterone biosynthetic defect. The emergency department should not delay steroid treatment while awaiting the result, because adrenal crisis can be fatal.
3. How would you counsel the family about diagnosis, gender, and inheritance?
Read the worked answer
I would explain that the infant has a life-threatening hormone deficiency that is treatable, and that the genital appearance is due to excess adrenal androgens before birth. In 46,XX congenital adrenal hyperplasia, the internal reproductive organs are typically female, and most families and care teams raise the child as female, but this requires a multidisciplinary discussion and should not be decided in the emergency department. I would involve pediatric endocrinology, genetics, and a psychosocial team. The condition is autosomal recessive; with consanguinity, the recurrence risk is 25% for each pregnancy. I would explain that future pregnancies can be tested prenatally and that the parents should receive genetic counseling. Long-term treatment includes glucocorticoid and mineralocorticoid replacement, stress dosing, growth monitoring, and attention to fertility and psychosexual development.